[1]邓小梅,李长明,楼宇梁,等.活血方定向透药联合常规康复疗法治疗斜外侧入路腰椎椎间融合术后残留腰腿痛的临床研究[J].中医正骨,2024,36(04):21-27,36.
　DENG Xiaomei,LI Changming,LOU Yuliang,et al.Directional transdermal iontophoresis of Huoxue Fang(活血方)combined with conventional rehabilitation therapy for treatment of residual lumbocrural pain following oblique lumbar interbody fusion:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(04):21-27,36.
点击复制

活血方定向透药联合常规康复疗法治疗斜外侧入路腰椎椎间融合术后残留腰腿痛的临床研究()
分享到：

《中医正骨》[ISSN:1001-6015/CN:41-1162/R]

卷:
第36卷
期数:
2024年04期
页码:
21-27,36
栏目:
临床研究
出版日期:
2024-04-20

文章信息/Info

Title:
Directional transdermal iontophoresis of Huoxue Fang(活血方)combined with conventional rehabilitation therapy for treatment of residual lumbocrural pain following oblique lumbar interbody fusion:a clinical study
作者:
邓小梅; 李长明; 楼宇梁; 方燕芬; 胡丽娟; 全仁夫
杭州市萧山区中医院,浙江 杭州 311201
Author(s):
DENG Xiaomei; LI Changming; LOU Yuliang; FANG Yanfen; HU Lijuan; QUAN Renfu
Xiaoshan Hospital of Traditional Chinese Medicine,Hangzhou 311201,Zhejiang,China
关键词:
手术后并发症;  腰腿痛;  脊柱融合术;  康复;  外治疗法;  中医定向透药;  临床试验
Keywords:
postoperative complications;  lumbago leg pain;  spinal fusion;  rehabilitation;  external treatment;  traditional chinese medicine targeted transdermal medicine;  clinical trial
摘要:
目的:探讨活血方定向透药联合常规康复疗法治疗斜外侧入路腰椎椎间融合术(oblique lumbar interbody fusion,OLIF)后残留腰腿痛的临床疗效。方法:将62例OLIF术后残留腰腿痛的患者随机分为联合康复疗法组和常规康复疗法组,每组31例。常规康复疗法组采用口服塞来昔布胶囊和乙哌立松片及常规康复锻炼治疗,联合康复疗法组在常规康复疗法的基础上联合活血方定向透药治疗; 2组均治疗14 d。记录并比较2组患者治疗前和治疗结束时的腰腿疼痛视觉模拟量表(visual analogue scale,VAS)评分、Oswestry功能障碍指数(Oswestry disability index,ODI)、左侧腰大肌横截面积(cross-sectional area,CSA),简明健康状况调查表(short form 36 health survey questionnaire,SF-36)中的生理功能、社会功能、精神健康、生理职能评分,以及血清肌酸激酶(creatine kinase,CK)、白细胞介素(interleukin,IL)-1、IL-6含量。结果:试验过程中,2组均无脱落病例。①腰腿疼痛VAS评分。治疗结束时,2组患者腰腿疼痛VAS评分均低于治疗前[(6.84±0.86)分,(0.90±0.54)分,t=32.561,P=0.000;(6.97±0.95)分,(1.35±0.61)分,t=27.744,P=0.000],联合康复疗法组患者腰腿疼痛VAS评分低于常规康复疗法组(t=3.095,P=0.004)。②ODI。治疗结束时,2组患者ODI均低于治疗前[(18.65±2.56)%,(8.16±2.27)%,t=17.058,P=0.000;(18.29±2.52)%,(9.97±1.83)%,t=14.869,P=0.000],联合康复疗法组患者ODI低于常规康复疗法组(t=3.450,P=0.002)。③左侧腰大肌CSA。治疗结束时,2组患者左侧腰大肌CSA均小于治疗前[(922.15±18.21)mm2,(784.89±19.02)mm2,t=29.024,P=0.000;(917.93±17.41)mm2,(801.38±13.26)mm2,t=29.652,P=0.000],联合康复疗法组患者左侧腰大肌CSA小于常规康复疗法组(t=3.959,P=0.000)。④SF-36中的生理功能、社会功能、精神健康及生理职能评分。治疗结束时,2组患者生理功能、社会功能、精神健康及生理职能评分均高于治疗前[生理功能评分:(51.42±3.02)分,(72.32±3.34)分,t=25.846,P=0.000;(50.68±2.56)分,(63.42±3.89)分,t=15.237,P=0.000; 社会功能评分:(58.03±3.24)分,(81.39±4.10)分,t=24.898,P=0.000;(58.19±3.82)分,(74.13±2.79)分,t=18.770,P=0.000; 精神健康评分:(61.32±4.44)分,(83.97±3.45)分,t=22.432,P=0.000;(61.26±4.73)分,(73.68±3.44)分,t=11.832,P=0.000; 生理职能评分:(60.71±3.39)分,(83.03±3.33)分,t=26.352,P=0.000;(61.29±3.05)分,(73.77±3.95)分,t=1.940,P=0.000],联合康复疗法组患者生理功能、社会功能、精神健康及生理职能评分均高于常规康复疗法组(t=9.670,P=0.000; t=8.154,P=0.000; t=11.763,P=0.000; t=9.980,P=0.000)。⑤血清CK、IL-1和IL-6含量。治疗结束时,2组患者血清CK、IL-1、IL-6含量均低于治疗前[血清CK含量:(303.29±14.61)U·L-1,(186.26±10.26)U·L-1,t=36.502,P=0.000;(301.06±10.85)U·L-1,(204.65±15.25)U·L-1,t=28.680,P=0.000; 血清IL-1含量:(3.89±0.15)pg·mL-1,(1.01±0.16)pg·mL-1,t=72.516,P=0.000;(3.87±0.18)pg·mL-1,(1.49±0.18)pg·mL-1,t=52.425,P=0.000; 血清IL-6含量:(13.73±0.84)pg·mL-1,(4.83±0.22)pg·mL-1,t=57.210,P=0.000;(13.45±1.12)pg·mL-1,(5.98±0.18)pg·mL-1,t=36.697,P=0.000],联合康复疗法组患者血清CK、IL-1、IL-6含量均低于常规康复疗法组(t=5.569,P=0.000; t=11.059,P=0.000; t=22.258,P=0.000)。结论:对于OLIF术后残留腰腿痛的患者,活血方定向透药联合常规康复疗法较单纯常规康复疗法能更好地降低炎症反应、减轻腰大肌水肿、缓解腰腿疼痛症状、改善腰椎功能和提高患者生活质量。
Abstract:
Objective:To explore the clinical outcomes of directional transdermal iontophoresis of Huoxue Fang(活血方,HXF)combined with conventional rehabilitation therapy for treatment of residual lumbocrural pain emerged after oblique lumbar interbody fusion(OLIF).Methods:Sixty-two patients with residual lumbocrural pain after OLIF were randomized into combined rehabilitation therapy group and conventional rehabilitation therapy group,31 cases in each group.All patients in the 2 groups were treated with oral application of celecoxib capsules and eperisone tablets,followed by conventional rehabilitation exercises; while the ones in combined rehabilitation therapy group were further treated with directional transdermal iontophoresis of HXF.All patients were treated for consecutive 14 days.The lumbocrural pain visual analogue scale(VAS)score,Oswestry disability index(ODI),cross-sectional area(CSA)of the left psoas major muscle,the scores for physical functioning(PF),social functioning(SF),mental health(MH),and role-physical(RP)in the short form 36 health survey questionnaire(SF-36)as well as the serum levels of creatine kinase(CK),interleukin(IL)-1,and IL-6 were recorded and compared between the 2 groups before the treatment and at the end of treatment,respectively.Results:During the trial,no patients dropped out of the study.①The lumbocrural pain VAS score decreased at the end of treatment compared to pretreatment in the 2 groups(6.84±0.86 vs 0.90±0.54 points,t=32.561,P=0.000; 6.97±0.95 vs 1.35±0.61 points,t=27.744,P=0.000),and it was lower in combined rehabilitation therapy group compared to conventional rehabilitation therapy group(t=3.095,P=0.004).②The ODI decreased at the end of treatment compared to pretreatment in the 2 groups(18.65±2.56 vs 8.16±2.27%,t=17.058,P=0.000; 18.29±2.52 vs 9.97±1.83%,t=14.869,P=0.000),and it was lower in combined rehabilitation therapy group compared to conventional rehabilitation therapy group(t=3.450,P=0.002).③The CSA of the left psoas major muscle decreased at the end of treatment compared to pretreatment in the 2 groups(922.15±18.21 vs 784.89±19.02 mm(2),t=29.024,P=0.000; 917.93±17.41 vs 801.38±13.26 mm(2),t=29.652,P=0.000),and it was smaller in combined rehabilitation therapy group compared to conventional rehabilitation therapy group(t=3.959,P=0.000).④The scores for PF,SF,MH and RP increased at the end of treatment compared to pretreatment in the 2 groups(score for PF:51.42±3.02 vs 72.32±3.34 points,t=25.846,P=0.000; 50.68±2.56 vs 63.42±3.89 points,t=15.237,P=0.000; score for SF:58.03±3.24 vs 81.39±4.10 points,t=24.898,P=0.000; 58.19±3.82 vs 74.13±2.79 points,t=18.770,P=0.000; score for MH:61.32±4.44 vs 83.97±3.45 points,t=22.432,P=0.000; 61.26±4.73 vs 73.68±3.44 points,t=11.832,P=0.000; score for RP:60.71±3.39 vs 83.03±3.33 points,t=26.352,P=0.000; 61.29±3.05 vs 73.77±3.95 points,t=1.940,P=0.000),and they were higher in combined rehabilitation therapy group compared to conventional rehabilitation therapy group(t=9.670,P=0.000; t=8.154,P=0.000; t=11.763,P=0.000; t=9.980,P=0.000).⑤The serum levels of CK,IL-1 and IL-6 decreased at the end of treatment compared to pretreatment in the 2 groups(serum level of CK:303.29±14.61 vs 186.26±10.26 U/L,t=36.502,P=0.000; 301.06±10.85 vs 204.65±15.25 U/L,t=28.680,P=0.000; serum level of IL-1:3.89±0.15 vs 1.01±0.16 pg/mL,t=72.516,P=0.000; 3.87±0.18 vs 1.49±0.18 pg/mL,t=52.425,P=0.000; serum level of IL-6:13.73±0.84 vs 4.83±0.22 pg/mL,t=57.210,P=0.000; 13.45±1.12 vs 5.98±0.18 pg/mL,t=36.697,P=0.000),and they were lower in combined rehabilitation therapy group compared to conventional rehabilitation therapy group(t=5.569,P=0.000; t=11.059,P=0.000; t=22.258,P=0.000).Conclusion:Directional transdermal iontophoresis of HXF combined with conventional rehabilitation therapy can better reduce inflammatory response,alleviate psoas major muscle edema,relieve lumbocrural pain symptoms,improve lumbar function and the quality of life compared to conventional rehabilitation therapy alone in patients with residual lumbocrural pain after OLIF.

参考文献/References:

[1] 高显达,孙家元,李朝晖,等.斜外侧腰椎间融合术并发症研究进展[J].中华骨科杂志,2020,40(8):546-552.
[2] 过依莎,王辉昊,俞仲翔.腰椎术后综合征的中西医诊治进展[J].现代中西医结合杂志,2022,31(1):137-141.
[3] 韦金忠,凌义龙,沈兴潮.独活寄生汤加减对椎间盘突出症脊柱内镜术后残留腰痛的影响[J].中华全科医学,2020,18(11):1929-1932.
[4] 胡鸢.腰椎手术失败综合征[J].中国骨与关节杂志,2012,1(4):420-425.
[5] 中华医学会骨科学分会脊柱外科学组.腰椎斜外侧椎间融合术的临床应用指南[J].中华骨科杂志,2020,40(8):459-468.
[6] 方后山,陈家平.活血镇痛汤治疗腰椎间盘突出症经皮椎间孔镜下髓核摘除术后残留腰痛的临床效果[J].中国医药导报,2024,21(3):153-157.
[7] 吴睿清.补阳还五汤治疗腰椎管狭窄症患者OLIF术后残余痛(气虚血瘀型)的临床疗效观察[D].南昌:江西中医药大学,2022.
[8] 邱凤飞.腰突散联合腰背肌功能锻炼治疗腰椎管狭窄症TLIF术后残留腰痛的临床疗效观察[D].合肥:安徽中医药大学,2022.
[9] FAIRBANK J C,PYNSENT P B.The Oswestry disability index[J].Spine(Phila Pa 1976),2000,25(22):2940-2952.
[10] BURHOLT V,NASH P.Short form 36(SF-36)health survey questionnaire:normative data for Wales[J].J Public Health(Oxf),2011,33(4):587-603.
[11] KIM K T,JO D J,LEE S H,et al.Oblique retroperitoneal approach for lumbar interbody fusion from L1 to S1 in adult spinal deformity[J].Neurosurg Rev,2018,41(1):355-363.
[12] FUJIBAYASHI S,HYNES R A,OTSUKI B,et al.Effect of indirect neural decompression through oblique lateral interbody fusion for degenerative lumbar disease[J].Spine(Phila Pa 1976),2015,40(3):E175-E182.
[13] 董国顺,王保锁.推拿手法与中药汤剂治疗腰椎间盘突出症疗效[J].中国继续医学教育,2019,11(15):150-152.
[14] 黎鹏,程永婷,马峰,等.乳香没药精油自微乳的制备与抗炎镇痛作用评价[J].药物评价研究,2023,46(4):795-802.
[15] 曾鹏辉,窦晨,高家菊,等.丁香-肉桂药对挥发油的抗氧化作用研究[J].中国民族民间医药,2023,32(4):41-47.
[16] 李雨繁,李双,赵文吉,等.不同来源甘松化学成分含量分析与抗氧化活性研究[J].成都医学院学报,2023,18(5):545-548.
[17] 杨启培,陈锋,崔伟,等.山柰酚活性单体治疗骨质疏松症的相关信号通路[J].中国组织工程研究,2024,28(26):4242-4249.
[18] 先梦麟,耿娜娜,邓琳,等.山柰酚调控细胞衰老治疗类风湿性关节炎的体外研究[J].陆军军医大学学报,2023,45(12):1281-1291.
[19] 苏玉,勘静.中药川乌与草乌的鉴别比较及药理活性分析[J].当代医药论丛,2020,18(7):57-58.
[20] 王明华,赵二劳,杨洁,等.白芷香豆素提取及其药理作用研究进展[J].中华中医药学刊,2023,41(10):234-237.
[21] 刘美婷,王连嵋,孟晶,等.细辛的化学成分、药理及毒理研究进展[J].中国实验方剂学杂志,2023,29(10):224-234.
[22] 吴谕锋,朱泽宇,陈靖南,等.冰片药理作用及冰片酯的研究进展[J].药学研究,2020,39(4):217-224.
[23] 王晶,张金伟,张艺蓉,等.丁香酚酯及肉桂醇酯对氟比洛芬透皮吸收的影响[J].世界科学技术-中医药现代化,2023,25(5):1796-1802.
[24] 邢鲁豫.中医定向透药疗法配合针灸治疗腰椎间盘突出症的临床疗效探讨[J].中国实用医药,2023,18(13):146-149.
[25] 季宏昌,黄湘龙,刘耀远,等.张伯礼运用乳香-没药对药治疗顽痹经验[J].中医杂志,2023,64(19):1961-1963.
[26] 左世国,李姣姣,向昱阳.《医宗金鉴·正骨心法要旨》中骨伤外治处方的用药规律分析[J].中医正骨,2022,34(2):40-43.
[27] 李辉诚,钟燕珠,区炳雄,等.医疗用毒性中药饮片生川乌、生草乌使用情况分析与外治方药挖掘[J].中医药管理杂志,2023,31(1):111-115.

相似文献/References:

[1]万宏波,马海燕,蒋云霞,等.口服益气化瘀汤联合功能锻炼治疗腰椎退行性疾病 术后残留腰腿痛的临床研究[J].中医正骨,2015,27(06):1.
　WAN Hongbo,MA Haiyan,JIANG Yunxia,et al.Clinical study on oral application of Yiqi Huayu Tang(益气化瘀汤)combined with functional exercise for the treatment of postoperative residual lumbocrural pain in patients with lumbar degenerative disease[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(04):1.
[2]喻秋萍,唐萌芽,王峥峰,等.身痛逐瘀汤治疗腰椎间盘突出症的系统评价[J].中医正骨,2016,28(06):24.
　YU Qiuping,TANG Mengya,WANG Zhengfeng,et al.Efficacy of Shentong Zhuyu Tang(身痛逐瘀汤)for treatment of lumbar disc herniation:a systematic review[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(04):24.
[3]叶长青,张海林,张宝良.中药活血止痛酊中频导入联合推拿治疗腰椎间盘突出症血瘀证的临床研究[J].中医正骨,2016,28(09):27.
　YE Chang qing,ZHANG Hailin,ZHANG Baoliang.Clinical study on medium frequency iontophoresis of Huoxue Zhitong Ding(活血止痛酊)combined with manipulation for treatment of blood-stasis-type lumbar disc herniation[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(04):27.
[4]林宏衡,方坚.“通法”和“荣法”治疗腰椎退行性疾病所致腰腿痛[J].中医正骨,2019,31(01):28.
[5]赵启,赵明宇,杨萌,等.“辨三症”理论及其在慢性颈肩腰腿痛疾病诊疗中的应用[J].中医正骨,2020,32(05):19.

备注/Memo

备注/Memo:
基金项目:杭州市医药卫生科技项目(0020191135)
通讯作者:李长明 E-mail:lcmmail@126.com
更新日期/Last Update: 1900-01-01